Nucleic acid nanotechnology for cancer treatment

Jun-O Jin1, Gyurin Kim2, Juyoung Hwang3

  • 1Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University, Shanghai 201508, China; Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, South Korea.

Insights

Nucleic acid (NA) nanostructures show promise for cancer treatment through gene therapy and immunotherapy. This review covers NA applications, delivery methods, and future prospects in oncology.

Area of Science:

  • Biotechnology
  • Nanomedicine
  • Oncology

Background:

  • Cancer remains a significant global health challenge.
  • Nanotechnology offers novel therapeutic strategies for cancer.
  • Nucleic acid (NA)-based nanostructures are emerging as key players in cancer treatment.

Purpose of the Study:

  • To review the applications of NA nanostructures in cancer therapy.
  • To discuss current research trends in NA-based gene therapy and immunotherapy.
  • To explore the limitations and future prospects of these therapeutic approaches.

Main Methods:

  • Literature review of studies on NA-based nanostructures for cancer treatment.
  • Analysis of NA structures, including pure NA and hybrid forms.
  • Examination of delivery vehicles for therapeutic agents.

Main Results:

  • Various NA-based nanostructures (siRNA, miRNA, aptamers) are utilized for cancer treatment.
  • Both gene therapy and immunotherapy approaches are being advanced using NA.
  • Hybrid nanostructures integrating NA with other materials enhance therapeutic efficacy.

Conclusions:

  • NA-based nanostructures represent a promising frontier in cancer treatment.
  • Further research into delivery systems and therapeutic optimization is crucial.
  • NA-mediated gene therapy and immunotherapy hold significant potential for improving cancer patient outcomes.